Literature DB >> 31076402

Functional microRNA screen uncovers O-linked N-acetylglucosamine transferase as a host factor modulating hepatitis C virus morphogenesis and infectivity.

Katharina Herzog1,2, Simonetta Bandiera1,2, Sophie Pernot1,2, Catherine Fauvelle1,2, Frank Jühling1,2, Amélie Weiss2,3,4,5, Anne Bull6, Sarah C Durand1,2, Béatrice Chane-Woon-Ming2,7, Sébastien Pfeffer2,7, Marion Mercey8, Hervé Lerat8, Jean-Christophe Meunier6, Wolfgang Raffelsberger2,3,4,5, Laurent Brino2,3,4,5, Thomas F Baumert1,2,9, Mirjam B Zeisel1,2,10.   

Abstract

OBJECTIVE: Infection of human hepatocytes by the hepatitis C virus (HCV) is a multistep process involving both viral and host factors. microRNAs (miRNAs) are small non-coding RNAs that post-transcriptionally regulate gene expression. Given that miRNAs were indicated to regulate between 30% and 75% of all human genes, we aimed to investigate the functional and regulatory role of miRNAs for the HCV life cycle.
DESIGN: To systematically reveal human miRNAs affecting the HCV life cycle, we performed a two-step functional high-throughput miRNA mimic screen in Huh7.5.1 cells infected with recombinant cell culture-derived HCV. miRNA targeting was then assessed using a combination of computational and functional approaches.
RESULTS: We uncovered miR-501-3p and miR-619-3p as novel modulators of HCV assembly/release. We discovered that these miRNAs regulate O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT) protein expression and identified OGT and O-GlcNAcylation as regulators of HCV morphogenesis and infectivity. Furthermore, increased OGT expression in patient-derived liver tissue was associated with HCV-induced liver disease and cancer.
CONCLUSION: miR-501-3p and miR-619-3p and their target OGT are previously undiscovered regulatory host factors for HCV assembly and infectivity. In addition to its effect on HCV morphogenesis, OGT may play a role in HCV-induced liver disease and hepatocarcinogenesis. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  HCV; hepatitis C; hepatocyte; molecular mechanisms

Mesh:

Substances:

Year:  2019        PMID: 31076402      PMCID: PMC7613422          DOI: 10.1136/gutjnl-2018-317423

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   31.793


  53 in total

1.  Clinical development of hepatitis C virus host-targeting agents.

Authors:  Mirjam B Zeisel; Thomas F Baumert
Journal:  Lancet       Date:  2017-01-11       Impact factor: 79.321

2.  Role of post translational modifications and novel crosstalk between phosphorylation and O-beta-GlcNAc modifications in human claudin-1, -3 and -4.

Authors:  Azeem Mehmood Butt; Ishaque Badshah Khan; Mureed Hussain; Muhammad Idress; Jun Lu; Yigang Tong
Journal:  Mol Biol Rep       Date:  2011-05-27       Impact factor: 2.316

3.  MicroRNAs regulate the immunometabolic response to viral infection in the liver.

Authors:  Ragunath Singaravelu; Shifawn O'Hara; Daniel M Jones; Ran Chen; Nathan G Taylor; Prashanth Srinivasan; Curtis Quan; Dominic G Roy; Rineke H Steenbergen; Anil Kumar; Rodney K Lyn; Dennis Özcelik; Yanouchka Rouleau; My-Anh Nguyen; Katey J Rayner; Tom C Hobman; David Lorne Tyrrell; Rodney S Russell; John Paul Pezacki
Journal:  Nat Chem Biol       Date:  2015-10-19       Impact factor: 15.040

Review 4.  miR-122--a key factor and therapeutic target in liver disease.

Authors:  Simonetta Bandiera; Sébastien Pfeffer; Thomas F Baumert; Mirjam B Zeisel
Journal:  J Hepatol       Date:  2014-10-13       Impact factor: 25.083

Review 5.  O-linked N-acetylglucosamine: the "yin-yang" of Ser/Thr phosphorylation? Nuclear and cytoplasmic glycosylation.

Authors:  G W Hart; K D Greis; L Y Dong; M A Blomberg; T Y Chou; M S Jiang; E P Roquemore; D M Snow; L K Kreppel; R N Cole
Journal:  Adv Exp Med Biol       Date:  1995       Impact factor: 2.622

6.  Evaluating the microRNA targeting sites by luciferase reporter gene assay.

Authors:  Yi Jin; Zujian Chen; Xiqiang Liu; Xiaofeng Zhou
Journal:  Methods Mol Biol       Date:  2013

7.  O-linked N-acetylglucosaminylation of Sp1 inhibits the human immunodeficiency virus type 1 promoter.

Authors:  Ramona Jochmann; Mathias Thurau; Susan Jung; Christian Hofmann; Elisabeth Naschberger; Elisabeth Kremmer; Thomas Harrer; Matthew Miller; Niels Schaft; Michael Stürzl
Journal:  J Virol       Date:  2009-02-04       Impact factor: 5.103

8.  Transcriptional response to hepatitis C virus infection and interferon-alpha treatment in the human liver.

Authors:  Tujana Boldanova; Aleksei Suslov; Markus H Heim; Anamaria Necsulea
Journal:  EMBO Mol Med       Date:  2017-06       Impact factor: 12.137

9.  Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis.

Authors:  Simonetta Bandiera; Sophie Pernot; Hussein El Saghire; Sarah C Durand; Christine Thumann; Emilie Crouchet; Tao Ye; Isabel Fofana; Marine A Oudot; Jochen Barths; Catherine Schuster; Patrick Pessaux; Markus H Heim; Thomas F Baumert; Mirjam B Zeisel
Journal:  J Virol       Date:  2016-06-24       Impact factor: 6.549

Review 10.  Glycan Shielding and Modulation of Hepatitis C Virus Neutralizing Antibodies.

Authors:  Muriel Lavie; Xavier Hanoulle; Jean Dubuisson
Journal:  Front Immunol       Date:  2018-04-27       Impact factor: 7.561

View more
  9 in total

1.  miR-492 Promotes Cancer Progression by Targeting GJB4 and Is a Novel Biomarker for Bladder Cancer.

Authors:  Kai Wang; Hang Lü; Hongchen Qu; Qingpeng Xie; Tao Sun; Ou Gan; Bin Hu
Journal:  Onco Targets Ther       Date:  2019-12-24       Impact factor: 4.147

2.  O-Linked N-Acetylglucosamine Modification of Mitochondrial Antiviral Signaling Protein Regulates Antiviral Signaling by Modulating Its Activity.

Authors:  Junghwa Seo; Yun Soo Park; Tae Hyun Kweon; Jingu Kang; Seongjin Son; Han Byeol Kim; Yu Ri Seo; Min Jueng Kang; Eugene C Yi; Yong-Ho Lee; Jin-Hong Kim; Boyoun Park; Won Ho Yang; Jin Won Cho
Journal:  Front Immunol       Date:  2021-02-02       Impact factor: 7.561

3.  Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation.

Authors:  Jie Hu; Qingzhu Gao; Yang Yang; Jie Xia; Wanjun Zhang; Yao Chen; Zhi Zhou; Lei Chang; Yuan Hu; Hui Zhou; Li Liang; Xiaosong Li; Quanxin Long; Kai Wang; Ailong Huang; Ni Tang
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

Review 4.  O-GlcNAcylation links oncogenic signals and cancer epigenetics.

Authors:  Lidong Sun; Suli Lv; Tanjing Song
Journal:  Discov Oncol       Date:  2021-11-24

Review 5.  Protein O-GlcNAcylation Regulates Innate Immune Cell Function.

Authors:  Hong Dong; Zihao Liu; Haitao Wen
Journal:  Front Immunol       Date:  2022-02-03       Impact factor: 8.786

Review 6.  Roles of microRNAs in Hepatitis C Virus Replication and Pathogenesis.

Authors:  Hui-Chun Li; Chee-Hing Yang; Shih-Yen Lo
Journal:  Viruses       Date:  2022-08-15       Impact factor: 5.818

7.  Common and Strain-Specific Post-Translational Modifications of the Potyvirus Plum pox virus Coat Protein in Different Hosts.

Authors:  Marta Hervás; Sergio Ciordia; Rosana Navajas; Juan Antonio García; Sandra Martínez-Turiño
Journal:  Viruses       Date:  2020-03-12       Impact factor: 5.048

Review 8.  The role of O-GlcNAcylation in immunity against infections.

Authors:  Marjolein Quik; Cornelis H Hokke; Bart Everts
Journal:  Immunology       Date:  2020-08-26       Impact factor: 7.397

Review 9.  Role of O-Linked N-Acetylglucosamine Protein Modification in Cellular (Patho)Physiology.

Authors:  John C Chatham; Jianhua Zhang; Adam R Wende
Journal:  Physiol Rev       Date:  2020-07-30       Impact factor: 37.312

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.